Literature DB >> 8131302

Adenine for guanine substitution -78 base pairs 5' to the apolipoprotein (APO) A-I gene: relation with high density lipoprotein cholesterol and APO A-I concentrations.

F Civeira1, M Pocovi, A Cenarro, C Garces, J M Ordovas.   

Abstract

A common mutation, adenine (A) for guanidine (G) substitution (G/A) has been located -78 bp 5' to the apo A-I gene. This region has been shown to be involved in the transcriptional regulation of the apo A-I gene. Previous studies have shown that this mutation is associated with altered high density lipoprotein cholesterol (HDL-C) levels, although these findings have not been consistent. We have studied the frequency of this mutation in 125 subjects (60 males and 65 females) selected because they had HDL-C levels below the 25th (low HDL) or above the 75th (high HDL) percentile of the population distribution. The presence of the mutation was detected by Msp I digestion of a 259 bp fragment of PCR amplified DNA. The allele frequency was similar in both groups (0.20 for the lowest HDL group and 0.28 for the highest HDL group, p > 0.05), although a non-significant trend was observed in a higher frequency of the A/A genotype in the highest HDL females (17.5%) vs only 6.7% in the lowest HDL female group. In conclusion, in this population the G/A mutation was not significantly associated with HDL-C or apo A-I plasma levels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8131302     DOI: 10.1111/j.1399-0004.1993.tb03906.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

1.  Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?

Authors:  Sunita Dodani; Yanbin Dong; Haidong Zhu; Varghese George
Journal:  Indian J Hum Genet       Date:  2008-01

2.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

3.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

4.  Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease.

Authors:  Taranjit Singh Rai; Madhu Khullar; B S Sehrawat; Monica Ahuja; Praveen Kumar Sharma; Rajesh Vijayvergiya; Anil Grover
Journal:  Mol Cell Biochem       Date:  2008-04-09       Impact factor: 3.396

5.  Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.

Authors:  BiHong Liao; KeQi Cheng; ShaoHong Dong; HuaDong Liu; ZhengLei Xu
Journal:  Diagn Pathol       Date:  2015-07-16       Impact factor: 2.644

6.  ApolipoproteinA1-75 G/A (M1-) polymorphism and lipoprotein(a); anti- vs. pro-Atherogenic properties.

Authors:  Ali I Albahrani; Jannete J Usher; Mohammed Alkindi; Eileen Marks; L Ranganath; Said Al-yahyaee
Journal:  Lipids Health Dis       Date:  2007-08-06       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.